Page 31 - 中国全科医学2022-11

·1308· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

［2］中国高血压防治指南修订委员会，高血压联盟（中国），中华 lowering pharmacotherapy for the prevention of cardiovascular disease
医学会心血管病学分会，等 . 中国高血压防治指南（2018 年修 and death：an individual participant-level data meta-analysis［J］.
订版）［J］. 中国心血管杂志，2019，24（1）：24-56. DOI： Lancet，2021，398（10305）：1053-1064.
10.3969/j.issn.1007-5410.2019.01.002. ［8］ZHANG W L，ZHANG S Y，DENG Y，et al. Trial of intensive
［3］WHELTON P K，CAREY R M，ARONOW W S，et al. 2017 blood-pressure control in older patients with hypertension［J］.
ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ N Engl J Med，2021，385（14）：1268-1279. DOI：10.1056/
PCNA guideline for the prevention，detection，evaluation， NEJMoa2111437.
and management of high blood pressure in adults：a report of the ［9］WILLIAMS B，MANCIA G，SPIERING W，et al. 2018 ESC/ESH
American College of Cardiology/American Heart Association Task guidelines for the management of arterial hypertension［J］. Eur
Heart J，2018，39（33）：3021-3104.
Force on clinical practice guidelines ［J］. Journal of the American
［10］ARVANITIS M，QI G H，BHATT D L，et al. Linear and nonlinear
College of Cardiology，2018，71（19）：e127-248. DOI：
mendelian randomization analyses of the association between
10.1016/j.jacc.2017.11.006.
diastolic blood pressure and cardiovascular events：the J-curve
［4］LEUNG A A，NERENBERG K，DASKALOPOULOU S S，et al.
revisited［J］. Circulation，2021，143（9）：895-906.
Hypertension Canada's 2016 Canadian hypertension education
［11］JURASCHEK S P，HU J R，CLUETT J L，et al. Effects of
program guidelines for blood pressure measurement，diagnosis，
intensive blood pressure treatment on orthostatic hypotension：
assessment of risk，prevention，and treatment of hypertension［J］.
a systematic review and individual participant-based meta-
Can J Cardiol，2016，32（5）：569-588. DOI：10.1016/j.
analysis［J］. Ann Intern Med，2021，174（1）：58-68.
cjca.2016.02.066.
［12］LIP S，TAN L E，JEEMON P，et al. Diastolic blood pressure
［5］VISSEREN F L J，MACH F，SMULDERS Y M，et al. 2021
J-curve phenomenon in a tertiary-care hypertension clinic［J］.
ESC Guidelines on cardiovascular disease prevention in clinical
Hypertension，2019，74（4）：767-775. DOI：10.1161/HYPER
practice［J］. Eur Heart J，2021，42（34）：3227-3337. DOI： TENSIONAHA.119.12787.
10.1093/eurheartj/ehab484. ［13］CARDOSO C R L，SALLES G F. Associations between achieved
［6］Sprint Research Group，WRIGHT J T Jr，WILLIAMSON J D， ambulatory blood pressures and its changes with adverse outcomes
et al. A randomized trial of intensive versus standard blood-pressure in resistant hypertension：was there a J-curve for ambulatory blood
control［J］. N Engl J Med，2015，373（22）：2103-2116. pressures? ［J］. Hypertension，2021，77（6）：1895-1905.
DOI：10.1056/NEJMoa1511939. DOI：10.1161/HYPERTENSIONAHA.121.17200.
［7］Blood Pressure Lowering Treatment Trialists' Collaboration. Age- （收稿日期：2021-11-18；修回日期：2022-02-23）
stratified and blood-pressure-stratified effects of blood-pressure- （本文编辑：李婷婷）

（上接第 1304 页） outcomes［J］. Eur Respir Rev，2020，29（158）：200199.
［41］US Preventive Services Task Force，KRIST A H，DAVIDSON K DOI：10.1183/16000617.0199-2020.
W，et al. Screening for lung cancer：US Preventive Services Task ［47］MILNE S，LI X，YANG C X，et al. Inhaled corticosteroids
Force recommendation statement［J］. JAMA，2021，325（10）： downregulate SARS-CoV-2-related genes in COPD：results from a
962-970. DOI：10.1001/jama.2021.1117. randomised controlled trial［J］. Eur Respir J，2021，58（1）：
［42］PARK H Y，KANG D，SHIN S H，et al. Chronic obstructive 2100130. DOI：10.1183/13993003.00130-2021.
［48］MUNBLIT D，BOBKOVA P，SPIRIDONOVA E，et al. Incidence
pulmonary disease and lung cancer incidence in never smokers：
and risk factors for persistent symptoms in adults previously
a cohort study［J］. Thorax，2020，75（6）：506-509. DOI：
hospitalized for COVID-19［J］. Clin Exp Allergy，2021，51（9）：
10.1136/thoraxjnl-2019-213732.
1107-1120.
［43］GE F，FENG Y，HUO Z Y，et al. Inhaled corticosteroids and
［49］JONES R，DAVIS A，STANLEY B，et al. Risk predictors and
risk of lung cancer among chronic obstructive pulmonary disease
symptom features of long COVID within a broad primary care patient
patients：a comprehensive analysis of nine prospective cohorts［J］.
population including both tested and untested patients［J］. Pragmat
Transl Lung Cancer Res，2021，10（3）：1266-1276. DOI：
Obs Res，2021，12：93-104. DOI：10.2147/POR.S316186.
10.21037/tlcr-20-1126.
［50］THOMPSON M G，EDWARD S，SHAUN G，et al. Effectiveness
［44］RAYMAKERS A J，MCCORMICK N，MARRA C A，et al. Do
of COVID-19 vaccines in ambulatory and inpatient care
inhaled corticosteroids protect against lung cancer in patients with
settings［J］. N Engl J Med，2021，385（15）：1355-1371.
COPD? A systematic review［J］. Respirology，2017，22（1）：
DOI：10.1056/NEJMOA2110362.
61-70. DOI：10.1111/resp.12919. ［51］MARTINEZ F J，AGUSTI A，CELLI B R，et al. Treatment trials
［45］WU M F，JIAN Z H，HUANG J Y，et al. Post-inhaled in young patients with chronic obstructive pulmonary disease and
corticosteroid pulmonary tuberculosis and pneumonia increases lung pre-chronic obstructive pulmonary disease patients：time to move
cancer in patients with COPD［J］. BMC Cancer，2016，16（1）： forward［J］. Am J Respir Crit Care Med，2022，205（3）：
778. DOI：10.1186/s12885-016-2838-4. 275-287. DOI：10.1164/rccm.202107-1663SO.
［46］HIGHAM A，MATHIOUDAKIS A，VESTBO J，et al. COVID-19 （收稿日期：2022-01-17；修回日期：2022-02-10）
and COPD：a narrative review of the basic science and clinical （本文编辑：李婷婷）